Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
12.57
+0.01 (0.08%)
At close: Aug 1, 2025, 4:00 PM
12.33
-0.24 (-1.91%)
After-hours: Aug 1, 2025, 4:08 PM EDT
Accolade Market Cap
Zymeworks has a market cap or net worth of $940.80 million as of August 1, 2025. Its market cap has increased by 31.49% in one year.
Market Cap
940.80M
Enterprise Value
637.65M
1-Year Change
31.49%
Ranking
Category
Stock Price
$12.57
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $940.80M, an increase of 185.61%. That is a compound annual growth rate of 13.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 875.90M | -13.14% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.50B |
| Johnson & Johnson | 402.22B |
| AbbVie | 346.39B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.16B |
| UnitedHealth Group | 215.78B |
| Novo Nordisk | 211.90B |